Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cyclic GMP-specific phosphodiesterase inhibitors

Cyclic GMP-specific phosphodiesterase inhibitors

US Patent 5981527 · Granted Nov 9, 1999

Estimated economic value: $17,840,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heterocyclic amides as kinase inhibitors2022
Heterocyclic amides as kinase inhibitors2021
Heterocyclic amides as kinase inhibitors2020
Quinolinone derivatives2018
Isoquinoline compounds, a process for their preparation, and pharmaceutical comp2017
Quinolinone derivatives2015
Imidazo [4, 5-C] quinoline derivatives as bromodomain inhibitors2013
Phenyloxyalkanonic acid derivatives as hPPAR activators2007
Oxazol/thiazol-derivatives activators of the hPPAR-alpha receptor2007
1,2,4-oxadiazole derivatives as hPPAR alpha agonists2006
Carboline derivatives2006
Carboline derivatives as PDE5 inhibitors2006